Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

NCT04110418 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT04110418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04110418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate
Lead sponsor
Ain Shams University
Phase
Phase 2
Overall status
Unknown status
Start date
February 19, 2019
Completion date
February 19, 2020
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis, refractory shock